2026 ASCO Breast Cancer Highlights: PANKU-Breast02

• October 15, 2026

Musings From the Power List: Jason Bock

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

• by Jason Bock

• October 14, 2026

• 14 min

2026 ASCO Breast Cancer Highlights: BWEL

Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD discuss new research from the Breast Cancer Weight Loss (BWEL) trial, as well as recommendations for lifestyle, diet and GLP1 agonists.

• October 15, 2026

• 1 min

Associations between CT characteristics of lung cancer lesions and histologic subtypes in lung cancer screening

• by Erick Suazo-Zepeda, Geertruida H. de Bock, Noa Antonissen, Colin Jacobs, Firdaus A. A. Mohamed Hoesein, Hester A. Gietema, Grigory Sidorenkov, Rozemarijn Vliegenthart, Marjolein A. Heuvelmans

• October 7, 2026